Literature DB >> 17540246

The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.

Fiona M MacKenzie1, Ian M Gould, Julie Bruce, Jill Mollison, Dominique L Monnet, Vladimir Krcmery, Barry Cookson, Jos W M van der Meer.   

Abstract

This observational, cross-sectional study describes the role played by clinical microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. A total of 170 acute care hospitals from 32 European countries returned a questionnaire on antibiotic policies and practices implemented in 2001. Data on antibiotic use, expressed as Defined Daily Doses per 100 occupied bed-days (DDD/100 BD) were provided by 139 hospitals from 30 countries. A total of 124 hospitals provided both datasets. 121 (71%) of Clinical Microbiology departments and 66 (41%) of Pharmacy departments provided out of hours clinical advice. 70 (41%) of microbiology/infectious disease specialists and 28 (16%) of pharmacists visited wards on a daily basis. The majority of laboratories provided monitoring of blood cultures more than once per day and summary data of antibiotic susceptibility testing (AST) for empiric prescribing (86% and 73% respectively). Most of the key laboratory and pharmacy-led initiatives examined did not vary significantly by geographical location. Hospitals from the North and West of Europe were more likely to examine blood cultures more than once daily compared with other regions (p < 0.01). Hospitals in the North were least likely routinely to report susceptibility results for restricted antibiotics compared to those in the South-East and Central/Eastern Europe (p < 0.01). Hospital wards in the North were more likely to hold antibiotic stocks (100%) compared with hospitals in the South-East which were least likely (39%) (p < 0.001). Conversely, hospital pharmacies in the North were least likely to dispense antibiotics on an individual patient basis (16%) compared with hospital pharmacies from Southern Europe (60%) (p = 0.01). Hospitals that routinely reported susceptibility results for restricted antibiotics had significantly lower median total antibiotic use in 2001 (p < 0.01). Hospitals that provided prescribing advice outside normal working hours had significantly higher antibiotic use compared with institutions that did not provide this service (p = 0.01). A wide range of antibiotic stewardship measures was practised in the participating hospitals in 2001, although there remains great scope for expansion of those overseen by pharmacy departments. Most hospitals had active antibiotic stewardship programmes led by specialists in infection, although there is no evidence that these were associated with reduced antibiotic consumption. There was also no evidence that pharmacy services reduced the amount of antibiotics prescribed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540246     DOI: 10.1016/S0195-6701(07)60019-X

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study.

Authors:  Lucas Magedanz; Erci Maria Silliprandi; Rodrigo Pires dos Santos
Journal:  Int J Clin Pharm       Date:  2012-03-01

2.  A nationwide survey on involvement of clinical microbiologists in antibiotic stewardship programmes in large French hospitals.

Authors:  Marion Le Maréchal; Nelly Agrinier; Vincent Cattoir; Céline Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-08       Impact factor: 3.267

Review 3.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

4.  Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study.

Authors:  C Coupat; C Pradier; N Degand; P Hofliger; C Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-08       Impact factor: 3.267

Review 5.  Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals.

Authors:  Pedro Mas-Morey; Marta Valle
Journal:  Eur J Hosp Pharm       Date:  2017-12-16

7.  Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals.

Authors:  Jon B Haug; Randi Myhr; Asmund Reikvam
Journal:  BMC Med Res Methodol       Date:  2011-12-13       Impact factor: 4.615

8.  Antibiotic prophylaxis in organophosphorus poisoning: A study of health and economic outcomes.

Authors:  Asim Priyendu; K E Vandana; Muralidhar Varma; Nishitha Prabhu; Alsha Abdul Rahim; Anantha Naik Nagappa
Journal:  Saudi Pharm J       Date:  2016-07-30       Impact factor: 4.330

Review 9.  Prevention and Control of Antimicrobial Resistant Healthcare-Associated Infections: The Microbiology Laboratory Rocks!

Authors:  Alexandra S Simões; Isabel Couto; Cristina Toscano; Elsa Gonçalves; Pedro Póvoa; Miguel Viveiros; Luís V Lapão
Journal:  Front Microbiol       Date:  2016-06-07       Impact factor: 5.640

Review 10.  Antimicrobial Stewardship: The Need to Cover All Bases.

Authors:  N Deborah Friedman
Journal:  Antibiotics (Basel)       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.